Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia.

Giona F, Massimi I, Guarino ML, Santopietro M, Laurino M, Temperilli F, Palumbo G, Foà R, Pulcinelli FM.

Haematologica. 2019 Jun 6. pii: haematol.2019.226266. doi: 10.3324/haematol.2019.226266. [Epub ahead of print]

2.

Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression.

Massimi I, Alemanno L, Guarino ML, Guerriero R, Mancone M, Ceccacci A, Frati L, Angiolillo DJ, Pulcinelli FM.

Thromb Haemost. 2019 May;119(5):726-734. doi: 10.1055/s-0039-1678707. Epub 2019 Feb 13.

PMID:
30759486
3.

Non-steroidal anti-inflammatory drugs increase MRP4 expression in an endometriotic epithelial cell line in a PPARa dependent manner.

Massimi I, Pulcinelli FM, Piscitelli VP, Alemanno L, Maltese T, Guarino ML, Marci R, Canny GO, Frati L, Mallozzi M, Frega A, Caserta D.

Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8487-8496. doi: 10.26355/eurrev_201812_16549.

4.

MiR-21 role in aspirin-dependent PPARα and multidrug resistance protein 4 upregulation.

Massimi I, Alemanno L, Guarino ML, Guerriero R, Frati L, Biasucci L, Pulcinelli FM.

Res Pract Thromb Haemost. 2018 May 17;2(3):596-606. doi: 10.1002/rth2.12104. eCollection 2018 Jul.

5.

Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.

La Rosa G, Biasucci LM, Mandolini C, Massimi I, Copponi G, Pulcinelli FM, Crea F.

J Cardiovasc Med (Hagerstown). 2018 Oct;19(10):611-613. doi: 10.2459/JCM.0000000000000691.

PMID:
30015780
6.

Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity.

Alemanno L, Massimi I, Klaus V, Guarino ML, Maltese T, Frati L, Angiolillo DJ, Pulcinelli FM.

Thromb Haemost. 2018 Mar;118(3):490-501. doi: 10.1055/s-0038-1629920. Epub 2018 Feb 15.

PMID:
29448294
7.

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis.

Mardente S, Mari E, Massimi I, Tafani M, Guerriero R, Morsilli O, Pulcinelli FM, Bianchi ME, Zicari A.

Front Immunol. 2018 Jan 12;8:1946. doi: 10.3389/fimmu.2017.01946. eCollection 2017.

8.

New platelet functional method for identification of pathogenic antibodies in HIT patients.

Guarino ML, Massimi I, Mardente S, Lappa A, Donfrancesco S, Visentin GP, Pulcinelli FM.

Platelets. 2017 Nov;28(7):728-730. doi: 10.1080/09537104.2017.1293803. Epub 2017 Mar 13.

PMID:
28287032
9.

Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment.

Massimi I, Lotti LV, Temperilli F, Mancone M, Sardella G, Calcagno S, Turriziani O, Frati L, Pulcinelli FM.

Thromb Haemost. 2016 Nov 30;116(6):1100-1110. Epub 2016 Sep 29.

PMID:
27683757
10.

Letter by Iannuccelli et al Regarding Article, "Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke".

Iannuccelli C, Di Franco M, Pulcinelli FM.

Stroke. 2016 Sep;47(9):e226. doi: 10.1161/STROKEAHA.116.013868. Epub 2016 Jul 21. No abstract available.

PMID:
27444256
11.

Endometriosis allergic or autoimmune disease: pathogenetic aspects--a case control study.

Caserta D, Mallozzi M, Pulcinelli FM, Mossa B, Moscarini M.

Clin Exp Obstet Gynecol. 2016;43(3):354-7.

PMID:
27328490
12.

Laparoscopic versus laparotomic surgery for adnexal masses: role in elderly.

Pulcinelli FM, Schimberni M, Marci R, Bellati F, Caserta D.

World J Surg Oncol. 2016 Apr 7;14:105. doi: 10.1186/s12957-016-0861-1.

13.

A uterus soaked in blood with low haemoglobin in a case of unrecognized uterine sarcoma.

Pulcinelli FM, Catalano A, Malle G, Mossa B, Caserta D.

Eur J Gynaecol Oncol. 2016;37(1):122-5.

PMID:
27048123
14.

Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.

Nicolazzo C, Massimi I, Lotti LV, Vespa S, Raimondi C, Pulcinelli FM, Gradilone A, Gazzaniga P.

Chin J Cancer Res. 2015 Oct;27(5):491-6. doi: 10.3978/j.issn.1000-9604.2015.04.09.

15.

Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line.

Massimi I, Ciuffetta A, Temperilli F, Ferrandino F, Zicari A, Pulcinelli FM, Felli MP.

Mediators Inflamm. 2015;2015:607957. doi: 10.1155/2015/607957. Epub 2015 Sep 27.

16.

Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.

Temperilli F, Di Franco M, Massimi I, Guarino ML, Guzzo MP, Valesini G, Frati L, Pulcinelli FM.

Vascul Pharmacol. 2016 Jan;76:11-7. doi: 10.1016/j.vph.2015.06.016. Epub 2015 Jul 2.

PMID:
26141932
17.

HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer.

Mardente S, Mari E, Massimi I, Fico F, Faggioni A, Pulcinelli F, Antonaci A, Zicari A.

Biomed Res Int. 2015;2015:512027. doi: 10.1155/2015/512027. Epub 2015 May 27.

18.

Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry.

Pulcinelli FM, Massimi I, Zicari A.

J Am Coll Cardiol. 2015 May 19;65(19):2153-4. doi: 10.1016/j.jacc.2014.11.079. No abstract available.

19.

Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.

Temperilli F, Rina A, Massimi I, Montemari AL, Guarino ML, Zicari A, Pulcinelli FM.

Platelets. 2015;26(8):783-7. doi: 10.3109/09537104.2014.1003291. Epub 2015 Mar 3.

PMID:
25734355
20.

Calcific tendinitis of the shoulder.

DE Carli A, Pulcinelli F, Rose GD, Pitino D, Ferretti A.

Joints. 2014 Aug 1;2(3):130-6. eCollection 2014 Jul-Sep.

21.

Poor responders in IVF: an update in therapy.

Giovanale V, Pulcinelli FM, Ralli E, Primiero FM, Caserta D.

Gynecol Endocrinol. 2015 Apr;31(4):253-7. doi: 10.3109/09513590.2014.987228. Epub 2014 Dec 8. Review.

PMID:
25482873
22.

Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.

Patti G, De Caterina R, Abbate R, Andreotti F, Biasucci LM, Calabrò P, Cioni G, Davì G, Di Sciascio G, Golia E, Golino P, Malatesta G, Mangiacapra F, Marcucci R, Nusca A, Parato VM, Pengo V, Prisco D, Pulcinelli F, Renda G, Ricottini E, Ruggieri B, Santilli F, Sofi F, Zimarino M; Working Group on Thrombosis of the Italian Society of Cardiology.

Eur Heart J. 2014 Sep 1;35(33):2213-23b. doi: 10.1093/eurheartj/ehu279. Epub 2014 Jul 14. Review.

PMID:
25024407
23.

Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets.

Massimi I, Guerriero R, Lotti LV, Lulli V, Borgognone A, Romani F, Barillà F, Gaudio C, Gabbianelli M, Frati L, Pulcinelli FM.

Br J Clin Pharmacol. 2014 Dec;78(6):1343-53. doi: 10.1111/bcp.12432.

24.

CLEC-2-dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP.

Borgognone A, Navarro-Núñez L, Correia JN, Pollitt AY, Thomas SG, Eble JA, Pulcinelli FM, Madhani M, Watson SP.

J Thromb Haemost. 2014 Apr;12(4):550-9. doi: 10.1111/jth.12514.

25.

A functional interaction between TRPC/NCKX induced by DAG plays a role in determining calcium influx independently from PKC activation.

Pulcinelli FM, Trifirò E, Massimi I, Di Renzo L.

Platelets. 2013;24(7):554-9. doi: 10.3109/09537104.2012.750718. Epub 2012 Dec 18.

PMID:
23249278
26.

JNK2 is activated during ER stress and promotes cell survival.

Raciti M, Lotti LV, Valia S, Pulcinelli FM, Di Renzo L.

Cell Death Dis. 2012 Nov 22;3:e429. doi: 10.1038/cddis.2012.167.

27.

Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport.

Borgognone A, Pulcinelli FM.

Thromb Haemost. 2012 Nov;108(5):955-62. doi: 10.1160/TH12-04-0232. Epub 2012 Sep 26.

PMID:
23014861
28.

Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.

Barillà F, Pulcinelli FM, Mangieri E, Torromeo C, Tanzilli G, Dominici T, Pellicano M, Paravati V, Acconcia MC, Gaudio C.

Platelets. 2013;24(3):183-8. doi: 10.3109/09537104.2012.686072. Epub 2012 May 30.

PMID:
22646157
29.

Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy.

Niccoli G, Giubilato S, Leo A, Cosentino N, Fracassi F, Cataneo L, Porto I, Leone AM, Burzotta F, Trani C, Biasucci LM, Narducci ML, Pulcinelli FM, Crea F.

Thromb Haemost. 2012 Jul;108(1):133-9. doi: 10.1160/TH11-09-0635. Epub 2012 Apr 26.

PMID:
22535468
30.

Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.

Mattiello T, Guerriero R, Lotti LV, Trifirò E, Felli MP, Barbarulo A, Pucci B, Gazzaniga P, Gaudio C, Frati L, Pulcinelli FM.

J Am Coll Cardiol. 2011 Aug 9;58(7):752-61. doi: 10.1016/j.jacc.2011.03.049. Erratum in: J Am Coll Cardiol. 2011 Oct 18;58(17):1832.

31.

Thromboxane production in morbidly obese subjects.

Graziani F, Biasucci LM, Cialdella P, Liuzzo G, Giubilato S, Della Bona R, Pulcinelli FM, Iaconelli A, Mingrone G, Crea F.

Am J Cardiol. 2011 Jun 1;107(11):1656-61. doi: 10.1016/j.amjcard.2011.01.053. Epub 2011 Mar 23.

PMID:
21439532
32.

Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients.

Santoro C, Rago A, Biondo F, Conti L, Pulcinelli F, Laurenti L, Perrone MP, Baldacci E, Leporace A, Mazzucconi MG.

Haemophilia. 2010 Sep 1;16(5):805-12. doi: 10.1111/j.1365-2516.2010.02230.x. Epub 2010 Mar 24.

PMID:
20345392
33.

The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.

Trifiro E, Williams SA, Cheli Y, Furihata K, Pulcinelli FM, Nugent DJ, Kunicki TJ.

Blood. 2009 Aug 27;114(9):1893-9. doi: 10.1182/blood-2009-03-209510. Epub 2009 May 22.

34.

Effects of pomegranate juice and extract polyphenols on platelet function.

Mattiello T, Trifirò E, Jotti GS, Pulcinelli FM.

J Med Food. 2009 Apr;12(2):334-9. doi: 10.1089/jmf.2007.0640.

PMID:
19459734
35.

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.

Pulcinelli FM, Biasucci LM, Riondino S, Giubilato S, Leo A, Di Renzo L, Trifirò E, Mattiello T, Pitocco D, Liuzzo G, Ghirlanda G, Crea F.

Eur Heart J. 2009 May;30(10):1279-86. doi: 10.1093/eurheartj/ehp097. Epub 2009 Apr 3.

PMID:
19346231
36.

Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.

Gradilone A, Pulcinelli FM, Lotti LV, Trifirò E, Martino S, Gandini O, Gianni W, Frati L, Aglianò AM, Gazzaniga P.

Curr Cancer Drug Targets. 2008 Aug;8(5):414-20.

PMID:
18690847
37.

Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients.

Riondino S, Petrini N, Donato L, Torromeo C, Tanzilli G, Pulcinelli FM, Barillà F.

J Thromb Thrombolysis. 2009 Aug;28(2):151-5. doi: 10.1007/s11239-008-0254-6. Epub 2008 Jul 18.

PMID:
18636229
38.

Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.

Niccoli G, Giubilato S, Russo E, Spaziani C, Leo A, Porto I, Leone AM, Burzotta F, Riondino S, Pulcinelli F, Biasucci LM, Crea F.

Eur Heart J. 2008 Aug;29(15):1843-50. doi: 10.1093/eurheartj/ehn325. Epub 2008 Jul 10.

PMID:
18617477
39.

Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.

Riondino S, Trifirò E, Principessa L, Mascioletti S, Di Renzo L, Gaudio C, Biasucci LM, Crea F, Pulcinelli FM.

Thromb Res. 2008;122(3):359-65. doi: 10.1016/j.thromres.2007.12.011. Epub 2008 Mar 4.

PMID:
18295304
40.

Administration of minor polar compound-enriched extra virgin olive oil decreases platelet aggregation and the plasma concentration of reduced homocysteine in rats.

Priora R, Summa D, Frosali S, Margaritis A, Di Giuseppe D, Lapucci C, Ieri F, Pulcinelli FM, Romani A, Franconi F, Di Simplicio P.

J Nutr. 2008 Jan;138(1):36-41.

PMID:
18156401
41.

Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

Gradilone A, Pulcinelli FM, Lotti LV, Martino S, Mattiello T, Frati L, Aglianò AM, Gazzaniga P.

J Clin Oncol. 2007 Sep 20;25(27):4318-20; author reply 4320. No abstract available.

PMID:
17878487
42.

Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines.

Gradilone A, Silvestri I, Scarpa S, Morrone S, Gandini O, Pulcinelli FM, Gianni W, Frati L, Aglianò AM, Gazzaniga P.

Oncol Rep. 2007 Apr;17(4):823-8.

PMID:
17342322
43.

Effects on platelet function of combination etoposide and carboplatin chemotherapy in pediatric oncology patients.

Pignatelli P, Properzi E, Pisani M, Clerico A, Schiavetti A, Lenti L, Pulcinelli FM, Ferroni P, Gazzaniga PP.

Platelets. 1998;9(5):309-14.

PMID:
16793755
44.

Prenatal catheter placement for fetal cystic adenomatoid pulmonary malformation: a case report.

Viggiano MB, Naves do Amaral W, Peres Fonseca PS, Hamú ZC, Damasceno de Castro J, Pulcinelli F.

Fetal Diagn Ther. 2006;21(2):194-7.

PMID:
16491002
45.
46.

Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal.

Riondino S, Pulcinelli FM.

J Thromb Haemost. 2006 Jan;4(1):291-2; author reply 292-3. No abstract available.

47.

Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.

Pulcinelli FM, Riondino S, Celestini A, Pignatelli P, Trifirò E, Di Renzo L, Violi F.

J Thromb Haemost. 2005 Dec;3(12):2784-9.

48.

Aspirin resistance: position paper of the Working Group on Aspirin Resistance.

Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK; Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance.

J Thromb Haemost. 2005 Jun;3(6):1309-11. Epub 2005 May 9. No abstract available.

49.

Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents.

Riondino S, Lotti LV, Cutini L, Pulcinelli FM.

J Biol Chem. 2005 Feb 25;280(8):6504-10. Epub 2004 Dec 14.

50.

Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.

Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F.

J Am Coll Cardiol. 2004 Mar 17;43(6):979-84.

Supplemental Content

Loading ...
Support Center